-
1
-
-
40949107410
-
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects
-
Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer W, Shikuma C, et al.: Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J Infect Dis 2008;197:867-870.
-
(2008)
J Infect Dis
, vol.197
, pp. 867-870
-
-
Kuritzkes, D.R.1
Lalama, C.M.2
Ribaudo, H.J.3
Marcial, M.4
Meyer, W.5
Shikuma, C.6
-
2
-
-
79955477986
-
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): A European multicohort study
-
Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, et al.: Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): A European multicohort study. Lancet Infect Dis 2011;11:363-371.
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 363-371
-
-
Wittkop, L.1
Günthard, H.F.2
De Wolf, F.3
Dunn, D.4
Cozzi-Lepri, A.5
De Luca, A.6
-
3
-
-
0037043652
-
Antiretroviral-drug resistance among patients recently infected with HIV
-
Little SJ, Holte S, Routy J-P, Daar ES, Markowitz M, Collier AC, et al.: Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385-394.
-
(2002)
N Engl J Med
, vol.347
, pp. 385-394
-
-
Little, S.J.1
Holte, S.2
Routy, J.-P.3
Daar, E.S.4
Markowitz, M.5
Collier, A.C.6
-
4
-
-
0037055016
-
Time trends in primary HIV-1 drug resistance among recently infected persons
-
Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, et al.: Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002; 288:181-188.
-
(2002)
JAMA
, vol.288
, pp. 181-188
-
-
Grant, R.M.1
Hecht, F.M.2
Warmerdam, M.3
Liu, L.4
Liegler, T.5
Petropoulos, C.J.6
-
5
-
-
83755225761
-
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011
-
Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, et al.: British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med 2012;13:1-44.
-
(2012)
HIV Med
, vol.13
, pp. 1-44
-
-
Asboe, D.1
Aitken, C.2
Boffito, M.3
Booth, C.4
Cane, P.5
Fakoya, A.6
-
7
-
-
84864131448
-
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA Panel
-
Thompson MA, Aberg JA, Hoy JF, Benson C, Gu HF, Hammer SM, et al.: Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA Panel. J Am Med Assoc 2012;308: 387-402.
-
(2012)
J Am Med Assoc
, vol.308
, pp. 387-402
-
-
Thompson, M.A.1
Aberg, J.A.2
Hoy, J.F.3
Benson, C.4
Gu, H.F.5
Hammer, S.M.6
-
8
-
-
80053065898
-
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
-
Vandamme A-M, Camacho RJ, Ceccherini-Silberstein F, de Luca A, Palmisano L, Paraskevis D, et al.: European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev 2011;13:77-108.
-
(2011)
AIDS Rev
, vol.13
, pp. 77-108
-
-
Vandamme, A.-M.1
Camacho, R.J.2
Ceccherini-Silberstein, F.3
De Luca, A.4
Palmisano, L.5
Paraskevis, D.6
-
10
-
-
70149095523
-
Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
-
Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al.: Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49:651-681.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 651-681
-
-
Aberg, J.A.1
Kaplan, J.E.2
Libman, H.3
Emmanuel, P.4
Anderson, J.R.5
Stone, V.E.6
-
11
-
-
67649188260
-
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries
-
Aghokeng AF, Vergne L, Mpoudi-ngole E, Mbangue M, and Deoudje N: Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. Antivir Ther 2009;14: 401-411.
-
(2009)
Antivir Ther
, vol.14
, pp. 401-411
-
-
Aghokeng, A.F.1
Vergne, L.2
Mpoudi-Ngole, E.3
Mbangue, M.4
Deoudje, N.5
-
12
-
-
79953763329
-
Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam Tanzania
-
Mosha F, Urassa W, Aboud S, Lyamuya E, Sandstrom E, Bredell H, et al.: Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania. AIDS Res Hum Retroviruses 2011;27:377-382.
-
(2011)
AIDS Res Hum Retroviruses
, vol.27
, pp. 377-382
-
-
Mosha, F.1
Urassa, W.2
Aboud, S.3
Lyamuya, E.4
Sandstrom, E.5
Bredell, H.6
-
13
-
-
33750524856
-
The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
-
Bennett DE: The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world. Curr Opin Infect Dis 2006;19:607-614.
-
(2006)
Curr Opin Infect Dis
, vol.19
, pp. 607-614
-
-
Bennett, D.E.1
-
14
-
-
38149109662
-
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B
-
Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, et al.: Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol 2008;46:177-184.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 177-184
-
-
Ndembi, N.1
Abraha, A.2
Pilch, H.3
Ichimura, H.4
Mbanya, D.5
Kaptue, L.6
-
15
-
-
33846025131
-
Epidemiology of antiretroviral drug resistance in drug-naive persons
-
Geretti AM: Epidemiology of antiretroviral drug resistance in drug-naive persons. Curr Opin Infect Dis 2007; 20:22-32.
-
(2007)
Curr Opin Infect Dis
, vol.20
, pp. 22-32
-
-
Geretti, A.M.1
-
16
-
-
79954853192
-
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala
-
Ndembi N, Hamers RL, Sigaloff KCE, Lyagoba F, Magambo B, Nanteza B, et al.: Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. AIDS 2011;25: 905-910.
-
(2011)
AIDS
, vol.25
, pp. 905-910
-
-
Ndembi, N.1
Hamers, R.L.2
Sigaloff, K.C.E.3
Lyagoba, F.4
Magambo, B.5
Nanteza, B.6
-
17
-
-
84877998235
-
Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara Uganda
-
Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello R, et al.: Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One 2013;8: e63411.
-
(2013)
PLoS One
, vol.8
-
-
Kaida, A.1
Matthews, L.T.2
Kanters, S.3
Kabakyenga, J.4
Muzoora, C.5
Mocello, R.6
-
18
-
-
36148979682
-
Transmission of drugresistant HIV-1 from an infected individual to a caregiver
-
Brumme CJ, Harrigan PR, Preston EC, Dong WWY, Wynhoven B, Murphy C, et al.: Transmission of drugresistant HIV-1 from an infected individual to a caregiver. Antivir Ther 2007;12:1139-1144.
-
(2007)
Antivir Ther
, vol.12
, pp. 1139-1144
-
-
Brumme, C.J.1
Harrigan, P.R.2
Preston, E.C.3
Dong, W.W.Y.4
Wynhoven, B.5
Murphy, C.6
-
19
-
-
84862098342
-
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool
-
Woods CK, Brumme CJ, Liu TF, Chui CKS, Chu AL, Wynhoven B, et al.: Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J Clin Microbiol 2012;50:1936-1942.
-
(2012)
J Clin Microbiol
, vol.50
, pp. 1936-1942
-
-
Woods, C.K.1
Brumme, C.J.2
Liu, T.F.3
Chui, C.K.S.4
Chu, A.L.5
Wynhoven, B.6
-
20
-
-
62749200513
-
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
-
Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009;4:e4724.
-
(2009)
PLoS One
, vol.4
-
-
Bennett, D.E.1
Camacho, R.J.2
Otelea, D.3
Kuritzkes, D.R.4
Fleury, H.5
Kiuchi, M.6
-
21
-
-
33748879209
-
Rationale and uses of a public HIV drugresistance database
-
Shafer RW: Rationale and uses of a public HIV drugresistance database. J Infect Dis 2006;194(Suppl): S51-58.
-
(2006)
J Infect Dis
, vol.194
, Issue.SUPPL.
-
-
Shafer, R.W.1
-
22
-
-
0037250521
-
Human immunodeficiency virus reverse transcriptase and protease sequence database
-
Rhee S-Y, Gonzales MJ, Kantor R, Betts BJ, Ravela J, and Shafer RW: Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2003;31:298-303.
-
(2003)
Nucleic Acids Res
, vol.31
, pp. 298-303
-
-
Rhee, S.-Y.1
Gonzales, M.J.2
Kantor, R.3
Betts, B.J.4
Ravela, J.5
Shafer, R.W.6
-
23
-
-
4744355003
-
Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection
-
Alexander CS, Montaner JSG, Asselin JJ, Ting L, McNabb K, Harris M, et al.: Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection. Ther Drug Monit 2004;26:516-523.
-
(2004)
Ther Drug Monit
, vol.26
, pp. 516-523
-
-
Alexander, C.S.1
Montaner, J.S.G.2
Asselin, J.J.3
Ting, L.4
McNabb, K.5
Harris, M.6
-
24
-
-
40549113345
-
HIV-1 subtype as a determinant of disease progression
-
Kuritzkes DR: HIV-1 subtype as a determinant of disease progression. J Infect Dis 2008;197:638-639.
-
(2008)
J Infect Dis
, vol.197
, pp. 638-639
-
-
Kuritzkes, D.R.1
-
25
-
-
40549121269
-
Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection
-
Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, et al.: Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008;197:707-713.
-
(2008)
J Infect Dis
, vol.197
, pp. 707-713
-
-
Kiwanuka, N.1
Laeyendecker, O.2
Robb, M.3
Kigozi, G.4
Arroyo, M.5
McCutchan, F.6
-
26
-
-
34047207715
-
HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads
-
Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al.: HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180.
-
(2007)
J Infect Dis
, vol.195
, pp. 1177-1180
-
-
Baeten, J.M.1
Chohan, B.2
Lavreys, L.3
Chohan, V.4
McClelland, R.S.5
Certain, L.6
-
27
-
-
0035132179
-
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda
-
Morgan D, Kaleebu P, Whitworth J, Yirrell D, Rutebemberwa a., Shier R, et al.: The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda. Int J STD AIDS 2001;12:116-121.
-
(2001)
Int J STD AIDS
, vol.12
, pp. 116-121
-
-
Morgan, D.1
Kaleebu, P.2
Whitworth, J.3
Yirrell, D.4
Rutebemberwa, A.5
Shier, R.6
-
28
-
-
84906915612
-
-
World Health Organization Accessed May 27, 2013
-
World Health Organization: Surveillance of transmitted HIV drug resistance. 2013. www.who.int/hiv/topics/drug resistance/surveillance/en/index. html. Accessed May 27, 2013.
-
(2013)
Surveillance of Transmitted HIV Drug Resistance
-
-
-
29
-
-
84858988089
-
Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world
-
Frentz D, Boucher CA, van de Vijver DA, et al.: Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Rev 2012;14: 17-27.
-
(2012)
AIDS Rev
, vol.14
, pp. 17-27
-
-
Frentz, D.1
Boucher, C.A.2
Van De Vijver, D.A.3
-
30
-
-
84878295758
-
-
World Health Organization Geneva, Switzerland
-
World Health Organization: The HIV drug resistance report-2012. Geneva, Switzerland, 2012.
-
(2012)
The HIV Drug Resistance report-2012
-
-
-
31
-
-
84862515892
-
-
Uganda Ministry of Health Kampala, Uganda
-
Uganda Ministry of Health: Uganda Clinical Guidelines 2010. Kampala, Uganda, 2010.
-
(2010)
Uganda Clinical Guidelines 2010
-
-
-
32
-
-
84866987811
-
Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients
-
Yanik EL, Napravnik S, Hurt CB, Dennis A, Quinlivan EB, Sebastian J, et al.: Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients. J Acquir Immune Defic Syndr 2012; 61:258-262.
-
(2012)
J Acquir Immune Defic Syndr
, vol.61
, pp. 258-262
-
-
Yanik, E.L.1
Napravnik, S.2
Hurt, C.B.3
Dennis, A.4
Quinlivan, E.B.5
Sebastian, J.6
-
33
-
-
76249130812
-
Evolutionary dynamics of complex networks of HIV drugresistant strains: The case of San Francisco
-
Smith RJ, Okano JT, Kahn JS, Bodine EN, and Blower S: Evolutionary dynamics of complex networks of HIV drugresistant strains: The case of San Francisco. Science 2010; 327:697-701.
-
(2010)
Science
, vol.327
, pp. 697-701
-
-
Smith, R.J.1
Okano, J.T.2
Kahn, J.S.3
Bodine, E.N.4
Blower, S.5
-
34
-
-
84867079060
-
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis
-
Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DHJ, Gregson J, et al.: Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: A global collaborative study and meta-regression analysis. Lancet 2012;380:1250-1258.
-
(2012)
Lancet
, vol.380
, pp. 1250-1258
-
-
Gupta, R.K.1
Jordan, M.R.2
Sultan, B.J.3
Hill, A.4
Davis, D.H.J.5
Gregson, J.6
-
35
-
-
3042817611
-
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission
-
Delaugerre C, Morand-Joubert L, Chaix M-L, Picard O, Marcelin A-G, Schneider V, et al.: Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission. Antivir Ther 2004;9:415-421.
-
(2004)
Antivir Ther
, vol.9
, pp. 415-421
-
-
Delaugerre, C.1
Morand-Joubert, L.2
Chaix, M.-L.3
Picard, O.4
Marcelin, A.-G.5
Schneider, V.6
-
36
-
-
10644238065
-
Long-term persistence of primary genotypic resistance after HIV-1 seroconversion
-
Pao D, Andrady U, Clarke J, Dean G, Drake S, Fisher M, et al.: Long-term persistence of primary genotypic resistance after HIV-1 seroconversion. J Acquir Immune Defic Syndr 2004;37:1570-1573.
-
(2004)
J Acquir Immune Defic Syndr
, vol.37
, pp. 1570-1573
-
-
Pao, D.1
Andrady, U.2
Clarke, J.3
Dean, G.4
Drake, S.5
Fisher, M.6
-
37
-
-
33646017725
-
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time
-
Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard J-P, Galimand J, et al.: HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time. AIDS 2006; 20:159-170.
-
(2006)
AIDS
, vol.20
, pp. 159-170
-
-
Ghosn, J.1
Pellegrin, I.2
Goujard, C.3
Deveau, C.4
Viard, J.-P.5
Galimand, J.6
-
38
-
-
33645534025
-
Evolution of transmitted HIV-1 with drugresistance mutations in the absence of therapy: Effects on CD4 + T-cell count and HIV-1 RNA load
-
Bezemer D, de Ronde A, Prins M, Porter K, Gifford R, Pillay D, et al.: Evolution of transmitted HIV-1 with drugresistance mutations in the absence of therapy: Effects on CD4 + T-cell count and HIV-1 RNA load. Antivir Ther 2006;11:173-178.
-
(2006)
Antivir Ther
, vol.11
, pp. 173-178
-
-
Bezemer, D.1
De Ronde, A.2
Prins, M.3
Porter, K.4
Gifford, R.5
Pillay, D.6
-
39
-
-
4143113433
-
Persistence of primary drug resistance among recently HIV-1 infected adults
-
Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead C a, Busch MP, et al.: Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS 2004;18: 1683-1689.
-
(2004)
AIDS
, vol.18
, pp. 1683-1689
-
-
Barbour, J.D.1
Hecht, F.M.2
Wrin, T.3
Liegler, T.J.4
Ramstead, C.A.5
Busch, M.P.6
-
40
-
-
4143093674
-
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
-
Brenner B, Routy J-P, Quan Y, Moisi D, Oliveira M, Turner D, et al.: Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 2004;18:1653-1660.
-
(2004)
AIDS
, vol.18
, pp. 1653-1660
-
-
Brenner, B.1
Routy, J.-P.2
Quan, Y.3
Moisi, D.4
Oliveira, M.5
Turner, D.6
-
41
-
-
0347479194
-
Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus
-
Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, et al.: Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis 2003;37:1693-1698.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 1693-1698
-
-
Gandhi, R.T.1
Wurcel, A.2
Rosenberg, E.S.3
Johnston, M.N.4
Hellmann, N.5
Bates, M.6
-
42
-
-
0035037383
-
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy
-
Bacheler L, Jeffrey S, Hanna G, D'Aquila R, Wallace L, Logue K, et al.: Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999-5008.
-
(2001)
J Virol
, vol.75
, pp. 4999-5008
-
-
Bacheler, L.1
Jeffrey, S.2
Hanna, G.3
D'Aquila, R.4
Wallace, L.5
Logue, K.6
-
43
-
-
0002693981
-
Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility
-
Huang W, Limoli K, Sartoris K, et al.: Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility. Antiviral Ther 1999;4(Suppl 1): 50-51.
-
(1999)
Antiviral Ther
, vol.4
, Issue.SUPPL. 1
, pp. 50-51
-
-
Huang, W.1
Limoli, K.2
Sartoris, K.3
-
44
-
-
0031805095
-
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type
-
Fujiwara T, Sato A, El-farrash M, Abe K, Isaka Y, Kodama M, et al.: S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type. Antimicrob Agents Chemother 1998;42:1340-1345.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 1340-1345
-
-
Fujiwara, T.1
Sato, A.2
El-Farrash, M.3
Abe, K.4
Isaka, Y.5
Kodama, M.6
-
45
-
-
0027231438
-
A mutation in reverse transcriptase of bis(heteroaryl)piperazine- resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors
-
Dueweke TJ, Pushkarskaya T, Poppe SM, Swaney SM, Zhao JQ, Chen IS, et al.: A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. Proc Natl Acad Sci USA 1993;90:4713-4717.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 4713-4717
-
-
Dueweke, T.J.1
Pushkarskaya, T.2
Poppe, S.M.3
Swaney, S.M.4
Zhao, J.Q.5
Chen, I.S.6
-
46
-
-
34247583029
-
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
-
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, and Maartens G: Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007; 146(8):564-573.
-
(2007)
Ann Intern Med
, vol.146
, Issue.8
, pp. 564-573
-
-
Nachega, J.B.1
Hislop, M.2
Dowdy, D.W.3
Chaisson, R.E.4
Regensberg, L.5
Maartens, G.6
-
47
-
-
0034604276
-
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
-
Paterson DL, Swindells S, Mohr J, Brester M, and Vergis EN: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133(1):21-30.
-
(2000)
Ann Intern Med
, vol.133
, Issue.1
, pp. 21-30
-
-
Paterson, D.L.1
Swindells, S.2
Mohr, J.3
Brester, M.4
Vergis, E.N.5
-
48
-
-
48749086685
-
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-näve populations and associate with reduced treatment efficacy
-
Johnson J A, Li J-F, Wei X, Lipscomb J, Irlbeck D, Craig C, et al.: Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-näve populations and associate with reduced treatment efficacy. PLoS Med 2008;5: e158.
-
(2008)
PLoS Med
, vol.5
-
-
Johnson, J.A.1
Li, J.-F.2
Wei, X.3
Lipscomb, J.4
Irlbeck, D.5
Craig, C.6
-
49
-
-
77954192930
-
Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution
-
Johnson J and Geretti AM: Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution. J Antimicrob Chemother 2010; 65:1322-1326.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1322-1326
-
-
Johnson, J.1
Geretti, A.M.2
-
50
-
-
76449101531
-
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure
-
Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, et al.: Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis 2010;201: 662-671.
-
(2010)
J Infect Dis
, vol.201
, pp. 662-671
-
-
Paredes, R.1
Lalama, C.M.2
Ribaudo, H.J.3
Schackman, B.R.4
Shikuma, C.5
Giguel, F.6
-
51
-
-
61849172898
-
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatmentnaive patients significantly impact treatment outcomes
-
Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, et al.: Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatmentnaive patients significantly impact treatment outcomes. J Infect Dis 2009;199:693-701.
-
(2009)
J Infect Dis
, vol.199
, pp. 693-701
-
-
Simen, B.B.1
Simons, J.F.2
Hullsiek, K.H.3
Novak, R.M.4
MacArthur, R.D.5
Baxter, J.D.6
-
52
-
-
79953745195
-
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: A systematic review and pooled analysis
-
Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, et al.: Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: A systematic review and pooled analysis. JAMA 2011;305:1327-1335.
-
(2011)
JAMA
, vol.305
, pp. 1327-1335
-
-
Li, J.Z.1
Paredes, R.2
Ribaudo, H.J.3
Svarovskaia, E.S.4
Metzner, K.J.5
Kozal, M.J.6
-
53
-
-
73349116621
-
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy
-
Geretti AM, Fox Z V, Booth CL, Smith CJ, Phillips AN, Johnson M, et al.: Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 52:569-573.
-
(2009)
J Acquir Immune Defic Syndr
, vol.52
, pp. 569-573
-
-
Geretti, A.M.1
Fox, Z.V.2
Booth, C.L.3
Smith, C.J.4
Phillips, A.N.5
Johnson, M.6
-
54
-
-
65549129096
-
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy
-
Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, et al.: Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis 2009;48:1296-1305.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1296-1305
-
-
Geretti, A.M.1
Harrison, L.2
Green, H.3
Sabin, C.4
Hill, T.5
Fearnhill, E.6
-
55
-
-
84857656362
-
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy
-
Franzetti M, Violin M, Casazza G, Meini G, Callegaro A, Corsi P, et al.: Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy. Clin Microbiol Infect 2012;18:E66-70.
-
(2012)
Clin Microbiol Infect
, vol.18
-
-
Franzetti, M.1
Violin, M.2
Casazza, G.3
Meini, G.4
Callegaro, A.5
Corsi, P.6
|